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Summary
Conventional understanding of CD4 T cell develop-
ment is that the MHC class II molecules on cortical
thymic epithelial cell are necessary for positive selec-
tion, as demonstrated in mouse models. Clinical data,
however, show that hematopoietic stem cells recon-
stitute CD4 T cells in patients devoid of MHC class II.
Additionally, CD4 T cells generated from human stem
cells in immunocompromised mice were restricted to
human, but not mouse, MHC class II. These studies
suggest an alternative pathway for CD4 T cell devel-
opment that does not normally exist in mice. MHC
class II is expressed on developing human thymo-
cytes, indicating a possible role of MHC II on thymo-
cytes for CD4 T cell generation. Therefore, we created
mice in which MHC class II is expressed only on T
lineage cells. Remarkably, the CD4 compartment in
such mice is efficiently reconstituted with unique
specificity, demonstrating a novel thymocyte-driven
pathway of CD4 T cell selection.
Introduction
During T cell development in the thymus, T cells bear-
ing T cell receptor (TCR) that receive modest signals
from self-peptide/MHC II complexes survive and further
develop to CD4 or CD8 single-positive (SP) T cells
through a process called positive selection. Conversely,
strong or too little signal to TCR by the ligand leads
to cell death through negative selection or by neglect,
respectively (Sebzda et al., 1999). The net result of posi-
tive and negative selection is a mature T cell repertoire
that can respond to foreign peptides but not self-pep-
tides presented by self-MHC molecules in the periph-
ery. It is believed that the outcome of T cell selection
depends on the types of thymic epithelial cells (TEC)*Correspondence: chechang@iupui.eduthat present peptide/MHC II complexes to the developing
thymocytes. MHC class II expressed in cortical TEC
(cTEC) plays a critical and unique role for positive se-
lection of CD4 T cells, while negative selection is mainly
mediated by bone marrow (BM)-derived dendritic cells
(DC) and medullary TEC (mTEC) (Brocker et al., 1997;
Laufer et al., 1996; Starr et al., 2002). By using thymic
reaggregate cultures, BM chimeric mice, or targeted
expression of MHC class II molecules to different com-
partments of the thymus, several groups have demon-
strated that BM-derived antigen-presenting cells (APC)
fail to mediate positive selection of CD4 T cells (Ander-
son et al., 1994; Brocker et al., 1997; Ernst et al., 1996;
Markowitz et al., 1993).
Recently, hematopoietic cells (HPC) including thymo-
cytes were shown to be capable of supporting the de-
velopment of T cells. For example, CD1 expression on
DP thymocytes drives NKT cell development (Bende-
lac, 1995; Coles and Raulet, 2000), and MHC class Ib-
restricted CD8 cells are selected by HPC as well as TEC
(Urdahl et al., 2002). In both cases, the ligand was ex-
pressed on thymocytes as well as APC. In addition,
several studies have demonstrated successful devel-
opment of human CD4 T cells from cord blood cells in
immunocompromised mice (Hiramatsu et al., 2003;
Saito et al., 2002; Traggiai et al., 2004; Yahata et al.,
2002). Unexpectedly, these human CD4 T cells re-
sponded to APC expressing human MHC, but not
mouse MHC, indicating that they developed by using
human MHC (Traggiai et al., 2004; Yahata et al., 2002).
Both constitutive and inducible expression of MHC
class II is critically regulated by the transcription factor
CIITA (LeibundGut-Landmann et al., 2004; Steimle et
al., 1993, 1994). CIITA also controls the expression of
other genes involved in MHC class II-restricted antigen
presentation, such as invariant chain and H-2M (Chang
and Flavell, 1995; Chin et al., 1994). In mice, MHC class
II molecules are expressed in APC (DC, macrophages,
and B cells) but not in T cells. In contrast, human CD4
T cells are known to express CIITA and MHC class II
upon activation. In addition, several groups have re-
ported that a significant proportion of human fetal and
postnatal thymocytes express MHC class II molecules
(Gilhus and Matre, 1983; Marinova et al., 2001; Park et
al., 1992; Thulesen et al., 1999). In a thymic reaggregate
culture system in vitro (Choi et al., 1997), MHC class II-
expressing human DP thymocytes seem to play a role
for their own positive selection through T-T interaction.
This positive selection process depends on MHC class
II, since the anti-MHC class II antibody completely
blocked the development of CD4 T cells (Choi et al.,
1997). Therefore, it is conceivable that human thymo-
cytes present antigens to other thymocytes, mediating
CD4 T cell development and playing a role in shaping
the T cell repertoire. This would also explain human
CD4 T cell development in mice. Together, these studies
suggest an alternative pathway for CD4 T cell develop-
ment that does not normally exist in mice.
To test whether MHC class II-expressing mouse thy-
mocytes can mediate positive selection, we investi-
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that express CIITA in thymocytes in the absence of
MHC class II in other cell types including TEC. Remark-
ably, these mice had a mature CD4 T cell compartment
in both the thymus and the periphery. Moreover, BM
chimera experiments showed that thymocytes could
mediate CD4 T cell selection, if they express MHC class
II. Functional CD4+CD25+ regulatory T cells were also
selected on thymocytes. However, TCR transgenic CD4
T cells were poorly selected on thymocytes, suggesting
that MHC-peptide complexes on thymocytes are dif-
ferent from that of TEC and select a distinct CD4 T cell
population. Nevertheless, CD4 T cells positively se-
lected on thymocytes responded to the cognate anti-
gen, indicating MHC class II-restricted development.
Together, these data demonstrate that MHC class II-
restricted CD4 T cells can be generated by two different
routes, via thymocyte- or TEC-mediated selection.
Results
CD4 T Cell Compartment Is Present in Mice
Expressing the CIITA Transgene in the Absence
of Endogenous CIITA
To ask whether CD4 T cells can be positively selected
on thymocytes, we generated transgenic mice that ex-
press human CIITA under the control of the CD4 pro-
moter lacking the CD8 silencer. Previously, we have
demonstrated that the transfection of CIITA to a mouse
T cell clone activated endogenous MHC class II, invari-
ant chain, and H-2M genes (Chang et al., 1995). Con-
sistent with this study, all subsets of thymocytes and
peripheral T cells in CIITA transgenic (CIITATg) mice ex-
pressed MHC class II, while MHC class II expression in
APC did not appear to be altered (Patel et al., 2005).
CIITATg mice showed an increased proportion of both
CD4 SP and CD8 SP cells in the thymus compared to
that of wild-type littermates (wt) (Figure 1).
To eliminate MHC class II expression in non-T cell
types including TEC, we crossed CIITATg mice with
CIITA−/− mice (CIITATg/CIITA−/−). In these mice, MHC
class II expression is expected to be restricted to the T
cells and possibly other cells that can activate the CD4
promoter. MHC class II expression was detected in all
T cells, but not APC, including B cells, macrophages,
and DC in the spleen (see Figure S1 in the Supplemen-
tal Data available with this article online). BM-derived
DC did not express MHC class II either (data not
shown). Therefore, the CD4 promoter used in the trans-
gene construct is not sufficient to be activated in other
cell types, and transgene expression is restricted to T
cells.
We next examined the composition of the lympho-
cytes in these mice. As reported previously (Chang et
al., 1996), CD4 T cell development was severely com-
promised in the CIITA−/− thymus and the peripheral lym-
phoid tissues compared to that of wt (Figures 1A and
1B). Surprisingly, the CD4 T cell compartment was re-
stored in CIITATg/CIITA−/− mice (Figures 1A–1C). The
numbers of CD4 T cells in the thymus as well as in
peripheral lymphoid tissues from wt and CIITATg/CIITA−/−
mice were also comparable, indicating that the expres-
sion of the CIITA transgene in CIITATg/CIITA−/− T cells
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Fompletely restored CD4 T cell selection in the absence
f endogenous CIITA (Figure 1D). However, there was a
-fold decrease in the total thymic cellularity in CIITATg/
IITA−/− mice compared to the control wt, CIITATg, or
IITA−/− mice (Figure 1E). We also observed that CII-
ATg/CIITA−/− mice had an increase in CD8 SP cells in
he thymus, which was similar to the CIITATg mice
Figures 1A and 1B). The increase in the CD8 SP com-
artment of CIITATg and CIITATg/CIITA−/− mice was as-
ociated with IL-4 signaling since CIITA transgene ex-
ression in IL-4−/− or Stat6−/− mice restored a normal
istribution of CD8 SP cells (Figure S2).
M from CIITATg Mice Generate CD4 T Cells in MHC
lass II-Deficient Hosts
hymic stromal cells of CIITA−/− mice express MHC
lass II at a very low level, but it is not sufficient for
D4 T cell selection (Chang et al., 1996). To eliminate
he contribution of the residual MHC class II expression
n TEC, we constructed BM chimeras. T-depleted BM
ells were prepared from wt or CIITATg donors and used
o reconstitute lethally irradiated MHC class II-deficient
β−/− or C57BL/6 (B6) recipients. After 2–3 months of
econstitution, thymocytes, splenocytes, and lymph
ode cells from reconstituted mice were analyzed for
D4 T cell development. As expected, wt BM was able
o reconstitute CD4 T cells in the B6 hosts, but not in
he Aβ−/− hosts (top two panels in Figures 2A and 2B).
emarkably, BM from CIITATg mice efficiently reconsti-
uted the CD4 T cell compartment in the thymus as well
s in the peripheral lymphoid tissues in the Aβ−/− mice,
s evidenced by the percentage and number of CD4 T
ells (bottom two panels in Figures 2A and 2B; Figure
C; and Table S1). We also examined kinetics of CD4
cell reconstitution in chimeric mice. Table S1 shows
steady repopulation of donor-derived thymocyte in
t/B6, CIITATg/B6, and CIITATg/Aβ−/− mice, start-
ng at 3 weeks after BM transplantation. As expected,
D4 T cells were not accumulated in wt/Aβ−/− chi-
eric mice. Although the number of CD4 SP in the thy-
us of CIITATg/Aβ−/− mice was less than the other two
roups, peripheral CD4 T cell numbers were compara-
le. CD8 T cells were reconstituted in all four groups,
ndicating successful engraftments of BM cells (Fig-
re 2D).
HC Class II Expression in Thymocytes Can
onfer CD4 T Cell Development
here are at least two possibilities that can explain CD4
cell development by CIITATg BM. First, thymocytes
riginated from CIITATg BM serve as APC due to the
xpression of genes necessary for MHC class II-restricted
ntigen presentation. Alternatively, ectopic expression
f CIITA may have altered gene expression in thymo-
ytes, altering the T cell selection process. To distin-
uish these two possibilities, we tested mice carrying
transgene for MHC class II I-E (I-ETg) under the con-
rol of the MHC class I promoter.
The I-E transgene was expressed in all lymphocytes
ncluding thymocytes (data not shown). BM from I-ETg
ice was transferred to irradiated B6 or Aβ−/− recipi-
nts, and the CD4 T cell compartment was examined.
igure 3A shows that I-E-expressing thymocytes could
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377Figure 1. CD4 T Cell Development in Mice Expressing CIITA Transgene but Not the Endogenous CIITA Gene
(A and B) Representative CD4 and CD8 expression profiles of the thymus (A) and the spleen (B) of wt, CIITA−/−, CIITATg, and CIITATg/CIITA−/−
mice. Mice were 7 weeks old. The numbers shown in the dot plots indicate the percentages of cells in each quadrant.
(C and D) Percentages and numbers of CD4 T cells, respectively. Results shown are the average and standard error from four mice per group.
(E) Thymic cellularity of indicated mice at 7 to 12 weeks old. Each symbol represents an individual mouse and the bars mark the median
numbers of total thymocytes for each group of mice.mediate positive selection of CD4 T cells, albeit at a
lower efficiency than that of CIITATg thymocytes (com-
pare to Figures 2A and 2B). Therefore, MHC class II,
not other gene products affected by CIITA, is responsi-
ble for CD4 T cell development. More efficient CD4 T
cell selection by CIITATg than I-ETg thymocytes could
be attributed to the fact that CIITA can activate other
genes that directly participate in MHC class II antigen
processing and presentation. Indeed, CIITATg thymo-
cytes expressed higher levels of Ii and H-2M genes
(data not shown). It should be noted that MHC class II
gene expression itself is required for CD4 T cell selec-
tion since CD4 T cells were absent in mice expressing
the CIITA transgene in Aβ−/− mice (Figure S3). Together,our data demonstrate that MHC class II expression in
thymocytes can support CD4 T cell development.
TEC in Chimeric Mice Do Not Express MHC Class II
Many studies have described the intercellular transfer
of membrane proteins from APC to interacting T cells
(Huang et al., 1999; Hudrisier and Bongrand, 2002; Mer-
kenschlager, 1996; Sharrow et al., 1981). Peptide-MHC
class I complexes were shown to be acquired by CD8
T cells (Huang et al., 1999), and donor-derived thymo-
cytes were able to obtain MHC class II molecules from
TEC as demonstrated in BM chimeric studies (Mer-
kenschlager, 1996; Sharrow et al., 1981). A reciprocal
transfer of molecules from T cells to other cell types
Immunity
378Figure 2. CD4 T Cell Selection on Thymocytes
(A and B) Profiles of CD4 and CD8 cell compartments in the thymus (A) and the spleen (B) of BM chimeric mice indicated at the top of each
dot plot.
(C) The percentages of CD4 T cells present in chimeric mice are shown.
(D) CD8 T cells were used as a control. The mice were analyzed 2–3 months after BM transplantation, and the results are the average and
standard error from 4–7 mice per group.has not been reported. However, if there was an
acquisition of MHC class II molecules by Aβ−/− TEC
from MHC class II-expressing thymocytes, CD4 T cells
present in BM chimeric mice and CIITATg/CIITA−/− mice
could have been selected on TEC, not thymocytes.
To test this possibility, we examined the MHC class II
status on TEC from chimeric mice. TEC were separated
from thymocytes and stained with antibodies that rec-
ognize MHC class II as well as cell-surface molecules
CDR1 and UEA1 that are differentially expressed in
subsets of TEC. MHC class II was not detectable on
either cTEC (Figure 3B) or mTEC (Figure 3C) from
CIITATg/Aβ−/− mice, similar to that of wt/Aβ−/−. In
contrast, TEC from B6 recipients expressed high levels
of MHC class II regardless of the source of donor.
Therefore, host TEC did not appear to acquire MHC
class II from BM-derived cells and, therefore, CD4 T cell
development in CIITATg/Aβ−/− chimera was most likely
mediated by MHC class II on thymocytes.
Phenotype of T Cells Selected on Thymocytes
Next, we compared the phenotype of CD4 T cells in the
periphery. Specifically, we examined the expression of
CD44, CD69, CD25, NK1.1, and TCR on the cell surface.
CD4 T cells in the CIITATg/Aβ−/− chimera expressed a
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pomparable level of all markers, except that the TCR
evel was slightly lower than control and the CD44hi
opulation was significantly enhanced (Figure 4A and
igure S4A). Similar phenotype was observed in CIITATg/
IITA−/− mice, although the increase of CD44hi cells was
oderate (2-fold) (Figure 4A and Figure S4B). These
ells were not recently activated cells, as shown by
D69 and CD25 profiles (Figure 4A and Figure S4C).
hese characteristics, low TCR and high CD44, resem-
le an enriched NKT cell population found in Aβ−/− mice
Figure 4A, second row; Coles and Raulet, 1994). How-
ver, the proportion of NK1.1+ T cells in both CIITATg
nd CIITATg/Aβ−/− mice was not significantly in-
reased, indicating that these CD4 T cells are conven-
ional CD4 T cells (Figure 4A and Figure S4D).
To compare the proliferative response of CD4 T cells
hat were selected on thymocytes versus TEC, we per-
ormed mixed lymphocyte reactions. CD4 T cells from
t, CIITATg, or CIITATg/CIITA−/− mice were labeled with
FSE and stimulated with either T-depleted MHC-
atched (H-2b) or -mismatched (H-2d) APC. As shown
n Figure 4B, wt or CIITATg CD4 T cells did not respond
o H-2b APC, indicating that they are self-tolerant. How-
ver, CIITATg/CIITA−/− CD4 T cells showed a significant
roliferation against H-2b APC. This may be due to the
CD4 T Cell Selection on Thymocytes
379Figure 3. MHC Class II on Thymocytes Is
Sufficient for CD4 T Cell Development
(A) B6 or Aβ−/− mice were reconstituted with
BM cells from MHC class II I-ETg mice for 2
months and analyzed for CD4 and CD8 cell
development. wt/Aβ−/− chimeric mice were
used as a negative control. Data shown are
representative of 2–6 mice.
(B and C) MHC class II expression in TEC.
TEC were prepared from chimeric mice as
indicated and stained with monoclonal anti-
bodies recognizing CD45, CDR1, UEA1, and
I-Ab. Histograms were gated on cTEC (B)
and mTEC (C) that are CD45−CDR1+UEA1−
and CD45−CDR1−UEA1+, respectively. Shaded
histograms are the I-Ab level on TEC from
Aβ−/− mice. Data are representative of two
independent experiments. Mice were ana-
lyzed 7 weeks after BM reconstitution.lack of MHC class II expression in DC and mTEC that
are responsible for negative selection of self-reactive T
cells. Upon stimulation with H-2d APC, all groups of
CD4 T cells proliferated (Figure 4B).
We also assessed proliferation capacity of CD4 T
cells from wt/B6, CIITATg/B6, and CIITATg/Aβ−/−
mice in response to H-2b or H-2d APC. As expected,
CD4 T cells from all groups showed alloreactivity to
H-2d (Figure 4C, bottom panels). Unlike CD4 T cells
from CIITATg/CIITA−/− mice, CD4 T cells that developed
in CIITATg/Aβ−/− chimeric mice did not proliferate
against H-2b APC (Figure 4C, top panels). Therefore,
MHC class II-positive hematopoietic cells, including
thymic DC, derived from CIITATg BM appeared to be
efficient to delete self-reactive T cells.
Functional CD4+CD25+ Regulatory Cells Can Be
Selected by Thymocytes
CD4+CD25+ regulatory T cells develop in the thymus
and are selected by TEC (reviewed by Fontenot and
Rudensky, 2005). MHC class II expression in cTEC was
shown to be necessary and sufficient for their develop-
ment (Bensinger et al., 2001). Therefore, we asked
whether MHC class II-expressing thymocytes can se-
lect regulatory T cells. The proportion of CD4+CD25+ T
cells in the thymus and peripheral lymphoid tissues ofCIITATg/CIITA−/− mice was somewhat lower than that of
wt and CIITATg mice (Figure 5A). It has been reported
that 5%–10% of peripheral CD4 T cells are CD4+CD25+
regulatory T cells (Piccirillo and Shevach, 2004; Saka-
guchi, 2005), and the CD4+CD25+ T cell population in
CIITATg/CIITA−/− spleen is within the lower limit at 4.2% ±
2.7%. CD28 engagement with B7 in developing thymo-
cytes was recently shown to be essential for optimal
generation of CD4+CD25+ regulatory T cells (Tai et al.,
2005). Therefore, the reduced number of CD4+CD25+
regulatory T cells in CIITATg/CIITA−/− mice may result
from the lack of adequate CD28/B7 interaction, since
CIITATg/CIITA−/− thymocytes do not express a signifi-
cant level of B7 molecules (data not shown).
We next compared their ability to suppress the prolif-
erative response of CD4+CD25− T cells in vitro. To do
this, we sorted CD4+CD25− cells from B6 mice, labeled
them with CFSE, and stimulated them in the presence
or absence of sorted CD4+CD25+ cells from wt, CIITATg,
and CIITATg/CIITA−/− mice. CFSE-labeled CD4+CD25−
responder T cells proliferated in the absence of regula-
tory T cells (Figure 5B). However, CD4+CD25+ regula-
tory cells, regardless of the source, were able to sup-
press the cell division of responders equally well.
CD4+CD25− cells from the same mice did not show
suppressive activity (data not shown). CD4+CD25+ cells
Immunity
380Figure 4. Characterization of CD4 T Cells in the Periphery
(A) CD4 T cells from BM chimeric mice reconstituted for 2 months were analyzed for the expression of cell-surface molecules as indicated
(top group). Wild-type and CIITATg/CIITA−/− CD4 T cells were also shown (bottom group). Histograms were gated on CD4 T cells. The percent-
ages of CD4 T cells expressing each molecule are shown except for TCRβ, which is mean fluorescence intensity. Similar results were obtained
from 3–6 mice.
(B and C) Mixed lymphocyte reactions by CD4 cells. Purified CD4 T cells from indicated mice were labeled with CFSE and stimulated with
irradiated and T-depleted H-2b or H-2d splenocytes for 4 days. Proliferation by responder CD4 T cells was measured by CFSE dilution.
Histograms show live CD4 cells. Chimeric mice were analyzed 3 months after BM reconstitution.Figure 5. Thymocytes Can Select Functional
CD4+CD25+ T Cells
(A) Percentages of CD4+CD25+ T cells in thy-
mic, LN, and spleen cell suspensions pre-
pared from 7- to 12-week-old mice. Aver-
ages and standard errors from 6–10 mice per
group were shown.
(B) CD4+CD25+ T cells from CIITATg/CIITA−/−
mice have normal suppressor function. Re-
sponder CD4+CD25− T cells from B6 mice
were sorted, labeled with CFSE, and cul-
tured in the presence of irradiated B6 APC
and the anti-CD3 antibody with or without
CD4+CD25+ T cells as indicated in each his-
togram. CD4+CD25+ T cells were also sorted
and the equal numbers of CD4+CD25+ T cells
were added to the culture. The histograms
were gated on CD4 T cells. The shaded
graph in each histogram represents prolifer-
ation of CD4+CD25− responder T cells with-
out CD4+CD25+ T cells. The open graphs
show CD4+CD25− responder cell proliferation in the presence of T regulatory cells from the source as indicated. The open area in the far left
represents CD4+CD25+ T cells that were not labeled with CFSE. The result is representative of two independent experiments.
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mice (Figure S4C), and they were functional suppressor
cells (data not shown). Therefore, MHC class II on thy-
mocytes can select functional CD4+CD25+ regulatory
T cells.
TCR Transgenic CD4 T Cells Are Poorly
Selected on Thymocytes
Having established the fact that MHC class II-express-
ing thymocytes can mediate CD4 T cell selection, we
wanted to test efficiency of positive selection using
TCR transgenic systems. For this purpose, we gener-
ated transgenic mice expressing the AND TCR and
CIITA transgenes on the H-2b background (AND/CIITA).
BM from AND/CIITA were tested for CD4 T cell genera-
tion. In AND/CIITA/B6 chimeric mice, we observed
the efficient generation of CD4 SP in the thymus (40%–
50% of total thymocytes) and the periphery (30%–40%)
(Figure 6A). Furthermore, a majority of CD4 SP and pe-
ripheral CD4 T cells expressed the high level of Vβ3
TCR, suggesting that those CD4 T cells were AND T
cells (Figure 6B). In contrast, AND/CIITA/Aβ−/− chi-
meric mice showed poor repopulation of CD4 cells, and
the resulting CD4 T cells were a mixture of three pop-
ulations including Vβ3hi, Vβ3low, and Vβ3− (Figure 6B).
Figure 6C further illustrates inefficient selection of AND
T cells by thymocytes, evidenced by the reduction of
Vβ3+ CD4 T cell numbers in the thymus and the periph-
ery of Aβ−/− recipients.
One limitation with the AND TCR system is the lack
of the clonotypic antibody recognizing AND-specific
cells. To overcome this, we have examined the genera-
tion of DO11.10 T cells. Since DO11.10 T cells are se-
lected on the H-2d background, Aβ−/− mice cannot be
used as recipients. Therefore, we used CIITA−/− mice on
the H-2d background and wild-type Balb/c (H-2d) mice
as recipients of BM from DO11.10 TCR transgenic mice
expressing the CIITA transgene (DO/CIITA). The pheno-
type of CIITA−/− mice on H-2d is indistinguishable from
that of H-2b (data not shown). Similar to AND T cells,
the CD4 SP population in the thymus was much lower
in CIITA−/− than Balb/c hosts (Figure 6D). When we ex-
amined DO11.10-specific T cells using the clonotypic
antibody KJ1-26, it was clear that the efficiency to se-
lect DO11.10 T cells was greatly diminished in CIITA−/−
hosts (Figures 6E and 6F). Therefore, both AND and
DO11.10 TCR transgenic cells were poorly selected on
thymocytes.
Next, we asked whether the residual population of
AND or DO11.10 TCR cells in the periphery respond to
cognate antigens. Total splenocytes from chimeric mice
were labeled with CFSE to monitor cell proliferation
prior to culturing them in the presence of the antigen
at varying doses and irradiated T-depleted APC. AND T
cells that are Vβ3hi from both AND/CIITA/B6 and AND/
CIITA/Aβ−/−chimeric mice underwent comparable pro-
liferation in an antigen dose-dependent manner (Figure
7A). The proliferation in the absence of the antigen is
likely due to alloreactivity against H-2k APC (Figure 7A).
In contrast, Vβ3− cells that are presumably non-AND
T cells showed similar proliferation regardless of the
antigen dose (Figure 7B). DO11.10 T cells also showed
antigen-dependent proliferation, which was indistin-guishable between TEC versus thymocytes-selected
cells (Figure 7C). Taken all together, our data showed
that TCR transgenic CD4 cells were poorly selected on
thymocytes. Nevertheless, the selected CD4 T cells,
through transgenic TCR or possibly a second TCR, re-
sponded to their cognate antigens in an MHC class II-
dependent manner.
Discussion
Many studies have documented that BM-derived cells
cannot mediate positive selection of CD4 T cells in vivo
(Anderson et al., 1994; Brocker et al., 1997; Ernst et al.,
1996; Markowitz et al., 1993). Recently, an increasing
number of studies have demonstrated that human HPC
can develop to mature CD4 T cells in immunocom-
promised mice (Hiramatsu et al., 2003; Saito et al.,
2002; Traggiai et al., 2004; Yahata et al., 2002). A most
recent study by Traggiai et al. (2004) reported that
CD34+ human cord blood cells could generate a func-
tional adaptive immune system, including CD4 T cells,
when transplanted into irradiated newborn Rag2−/−γc−/−
mice. Interestingly, CD4 T cells in these mice responded
to human but not mouse MHC expressed by APC in
the periphery tested by mixed lymphocyte reactions.
Similar studies using NOD/SCID/γc−/− mice as recipi-
ents also showed the successful development of hu-
man CD4 T cells from cord blood cells (Hiramatsu et
al., 2003; Yahata et al., 2002). These CD4 T cells were
polyclonal and responded to stimuli such as mitogenic,
cytokine, and allogeneic proliferation against human
MHC (Yahata et al., 2002). Furthermore, human IgM,
IgG, and IgA were present in plasma of these mice, indi-
cating competent helper cell functions of human CD4
T cells (Hiramatsu et al., 2003). Based on our current
study, human HPC, including thymocytes, that devel-
oped from the transferred CD34+ cord blood cells might
express human MHC class II and support their own
CD4 T cell development in mice. This would explain
allogeneic responses to human MHC.
The bare lymphocyte syndrome (BLS) is a hereditary
immunodeficiency caused by the absence of MHC
class II gene expression (Reith and Mach, 2001). The
key feature of BLS patients is lack of adoptive immune
responses against foreign antigens partly due to the
low number of CD4 T cells. BM transplantation is the
curative treatment of BLS and, interestingly, the pa-
tients that received BM transplantation showed the
restoration of CD4 T cells and immune function (God-
thelp et al., 2000; Klein et al., 1995). Presumably, MHC
class II expressed on donor-derived thymocytes were
responsible for the generation of CD4 T cells, since the
patients do not express their own MHC class II.
A considerable percentage (30%–50%) of human fe-
tal and postnatal thymocytes express MHC class II
molecules (Gilhus and Matre, 1983; Marinova et al.,
2001; Park et al., 1992; Thulesen et al., 1999). Under
normal conditions, it is likely that human thymocytes
can induce maturation of neighboring thymocytes.
Therefore, CD4 SP can be generated by two develop-
mental pathways: via interaction with TEC or with thy-
mocytes. These two pathways of CD4 T cell develop-
ment have significant implications for the immune
Immunity
382Figure 6. Transgenic TCR-Positive CD4 T Cells Are Poorly Selected on Thymocytes
(A–C) Development of AND T cells in AND/CIITA/B6 and AND/CIITA/Aβ−/− chimeric mice.
(A) CD4 versus CD8 distributions in the thymus and LN of chimeric mice 2 months after BM transplantation.
(B) Expression of Vβ3 on CD4 SP and CD4 T cells in the thymus and LN, respectively, of the same mice used in (A).
(C) Relative cell numbers of Vβ3hi CD4 SP and CD4 T cells in the thymus and the periphery of AND/CIITA/Aβ−/− chimeric mice. The total
Vβ3hiCD4+ T cell numbers in each lymphoid organ from the AND/CIITA/B6 mice were set at 100%. Averages and standard errors from 4–5
mice per group were shown.
(D–F) Selection of DO11.10 TCR cells in DO/CIITA/Balb/c and DO/CIITA/CIITA−/− BM chimeras.
(D) CD4 and CD8 profiles in the thymus and LN.
(E) Comparison of KJ1-26+TCRβ+ DO11.10 T cells in DP and CD4 SP populations from chimeras.
(F) Relative numbers of KJ1-26hi CD4 T cells in the thymus, LN, and the spleen from DO/CIITA/CIITA−/− chimeric mice as compared to those
from DO/CIITA/Balb/c chimeras. The total KJ1-26hi T cell numbers in each lymphoid organ from the DO/CIITA/B6 mice were set at 100%.
Mice were studied 11 weeks after BM reconstitution.response in the context of nonautologous human BM
transplantation. It is possible that a patient who re-
ceives nonautologous BM may have two CD4 T cell
populations selected on two distinct sets of MHC: one
population selected on MHC class II expressed by do-
nor-derived thymocytes, and the other on patient’s
MHC class II molecules present on TEC. In mice, thy-
mocytes do not express their own MHC class II, but
can acquire MHC from TEC (Merkenschlager, 1996;
Sharrow et al., 1981). It remains to be determined
whether these MHC class II-expressing mouse thymo-
c
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cytes are able to mediate positive selection. We sus-
ect that the frequency of thymocyte-mediated positive
election in mice is low simply because they do not
xpress their own endogenous MHC class II, and the
evel of acquired MHC class II may not be sufficient for
fficient selection.
It is puzzling as to why APC cannot mediate positive
election similar to CIITA- or MHC class II-expressing
hymocytes. There are at least three factors that might
ontribute to the difference. First, APC are primarily lo-
ated at the cortico-medullary junction or in the me-
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383Figure 7. Thymocyte-Selected TCR Transgenic CD4 T Cells Re-
spond to Cognate Antigens
(A and B) AND T cells. CFSE-labeled total splenocytes from AND/
CIITA/B6 and AND/CIITA/Aβ−/− chimeric mice were stimulated
with irradiated B10.BR (H-2k) splenocytes in the presence of pigeon
cytochrome C protein (0, 3, or 30 g/ml) for 4 days. Cells were
then stained with CD4 and anti-Vβ3 antibodies, and proliferation of
CD4+Vβ3hi (A) and CD4+Vβ3− (B) were shown. Mice were analyzed
2 months after BM reconstitution.
(C) DO11.10 T cells. CFSE-labeled total splenocytes from DO/
CIITA/Balb/c and DO/CIITA/CIITA−/− BM chimeric mice were
stimulated with irradiated Balb/c (H-2d) APC together with OVA pro-
tein (0, 10, or 100 g/ml) for 4 days. Cells were then stained with
CD4 and KJ1-26 antibodies and proliferation of KJ1-26+ cells were
shown. Studies were done 11 weeks after BM reconstitution.dulla, not in the cortex where positive selection occurs
(Ardavin, 1997; Brekelmans and van Ewijk, 1990; Gray
et al., 2005). However, MHC class II molecules on DC
were able to mediate CD4 T cell selection in thymic
reaggregate cultures, suggesting a positive role of thy-
mic DC for CD4 T cell selection (Yasutomo et al., 2000).
Second, the number of MHC class II-positive APC may
not be sufficient for selection of a detectable number
of T cells. Finally, APC are specialized for negative se-
lection and, therefore, may not be capable of carrying
out positive selection. Together, the cell type express-
ing MHC class II appears less critical, if the number of
MHC class II-positive cells is sufficient for CD4 T cell
selection. Consistent with this notion, MHC class II-
expressing fibroblasts have shown to be able to medi-
ate positive selection when they were injected into the
thymus, albeit at a low efficiency (Hugo et al., 1993).Moreover, the stromal cell line OP9 expressing Notch
ligand delta-like 1 (OP9-DL1) can support positive se-
lection of DP and CD8 SP from multiple sources of pre-
cursors in vitro (Schmitt et al., 2004; Schmitt and Zu-
niga-Pflucker, 2002; Terra et al., 2005; Zuniga-Pflucker,
2004). However, OP9-DL1 do not express MHC class II
molecules and therefore little or no positive selection
of CD4 SP was observed. It would be interesting to de-
termine whether the precursor cells from CIITATg can
differentiate to CD4 SP on OP9-DL1 cells.
Our study using CIITATg or I-ETg mice clearly demon-
strated the potential of thymocytes to mediate their
own selection. However, other components in the thy-
mus, such as stromal cells, soluble factors, and the or-
ganization of the thymic architecture, are likely to be
required for proper CD4 T cell selection. A study that
showed that the local availability of the ligand for pre-
cursor thymocytes controls lineage commitment further
strengthens the importance of the thymic microenviron-
ment (Canelles et al., 2003). In our system, developing
thymocytes would have ample opportunities to en-
counter MHC class II expressed in neighboring thymo-
cytes, resulting in maturation of the CD4 SP stage.
Moreover, the quality of the ligand provided by thymo-
cytes seems to be adequate to deliver a signal for sur-
vival. However, there seems to be a distinct difference
in the repertoire of MHC-peptide complexes between
TEC and thymocytes because both AND and DO11.10
TCR cells were poorly selected on thymocytes. We
cannot distinguish whether AND or DO11.10 TCR cells
were selected via the transgenic TCR or a second TCR.
The same transgenic mice on the RAG−/− or TCRα−/−
background would determine the selection specificity.
Nevertheless, it is tempting to speculate that since
these TCR genes were cloned from TEC-selected CD4
T cells, positive selection of TCR transgenic cells re-
quires the MHC-peptide complexes generated by TEC
not thymocytes. This also suggests that peptides
loaded on MHC class II by thymocytes do not com-
pletely overlap with those by TEC, which may increase
the diversity of the CD4 T cell repertoire. Further study
comparing two peptide pools would enhance our un-
derstanding.
Negative selection eliminates T cells with high affinity
to self-peptide/MHC complexes, which is critical for
self-tolerance. The primary cell types responsible for
negative selection are BM-derived APC and mTEC. In
CIITATg/CIITA−/− mice, CD4 T cells that have been posi-
tively selected on MHC class II-expressing thymocytes
may not have gone through negative selection because
neither APC nor mTEC express MHC class II. Thus, CD4
T cells that have emerged from the thymus in these
mice would be self-reactive and, therefore, can become
activated in the periphery in response to self-peptide/
MHC class II complexes. In fact, CD4 T cells selected
on thymocytes in CIITATg/CIITA−/− mice proliferated
against MHC-matched APC (Figure 4B). In contrast, the
Aβ−/− host reconstituted with HPC from CIITATg mice
had MHC class II-positive APC in the periphery (Figure
S5). Therefore, MHC class II-expressing APC including
DC were available in the thymus of CIITATg/Aβ−/−
chimeric mice, which should mediate negative selec-
tion by presenting ubiquitous antigens as well as tis-
sue-specific antigens that were picked up by APC (Gal-
Immunity
384legos and Bevan, 2004). Indeed, CD4 T cells from these
mice did not display significant spontaneous prolifera-
tion to MHC-matched APC (Figure 4C).
Our data showed the increased CD44hi CD4 T cells
similar to class Ib-restricted CD8 cells that have been
selected on thymocytes (Urdahl et al., 2002). CD44hi is
often considered as an effector/memory T cell marker.
However, it is not clear whether CD44hi CD4 T cells in
CIITATg/CIITA−/− and CIITATg/Aβ−/− mice are indeed
memory cells or if CD44hi cells arose in the periphery
because they might have undergone more homeostatic
proliferation due to the lymphopenic environment. It is
reported that CD4 T cells activated in the periphery can
reenter the thymus, especially in lymphopenic mice
(Agus et al., 1991). If this also occurs in our system, we
expected to have CD44hi thymocytes in the BM chi-
meric mice. However, CD4 SP thymocytes were CD44lo
(Figure S4A), suggesting that CD4 SP cells in the thy-
mus are not recirculating mature CD4 T cells from the
periphery. It is also possible that the lack of negative
selection by mTEC-expressing AIRE is responsible for
the CD44hi phenotype. Thymocytes do not express
AIRE, and AIRE-deficient mice showed the increase in
CD44hi cells (Anderson et al., 2002; Zuklys et al., 2000).
Taken together, it is likely that the lack of interaction
between TEC and developing thymocytes as well as
the increased homeostatic expansion of cells in the pe-
riphery may be responsible for the increase in CD44hi
cell numbers.
At the moment, it is not clear whether CD4 T cells
selected by thymocytes possess different functions or
not. CD4 T cells selected on thymocytes may have in-
distinguishable functions from that of TEC-selected
CD4 T cells, as shown in the previous reports (Hi-
ramatsu et al., 2003; Saito et al., 2002; Traggiai et al.,
2004; Yahata et al., 2002). On the other hand, it is
equally possible that each population of CD4 T cells
carries out a distinct role. Further investigation is war-
ranted to ascertain the biological significance of this
difference by comparing the function mediated by the
two populations of CD4 T cells during the immune re-
sponse in vivo.
Experimental Procedures
Mice
CIITATg mice were generated by expressing type III isoform of hu-
man CIITA under the control of a CD4 promoter/enhancer cassette
kindly provided by Dr. Dan Littman (New York University). Founder
lines were generated in a C57BL6/JxSJL background and subse-
quently backcrossed onto the C57BL6/J background more than 6
times. CIITATg mice were maintained as heterozygotes for the
transgene, and nontransgenic littermates were used as wild-type
(wt) control. CD45.1-positive CIITATg mice were generated by
crossing CIITATg mice on C57BL6/J background (CD45.2) with
CD45.1 congenic mice. MHC class II I-ETg mice were characterized
previously (Patel et al., 2004). C57BL/6 (designated as B6 in the
text), Balb/c (H-2d), B10.BR (H-2k), AND TCR transgenic mice (H-2b),
and DO11.10 TCR transgenic mice (H-2d) were purchased from the
Jackson Laboratory (Bar Harbor, ME). AND TCR or DO11.10 TCR
transgenic mice were crossed with CIITATg mice to generate AND/
CIITA (H-2b) and DO/CIITA (H-2d) double transgenic mice. The MHC
class II-deficient Aβ−/− mice were obtained from Taconic (German-
town, NY), and CIITA−/− (H-2d) mice were generated by backcross-
ing CIITA−/− (H-2b) mice with Balb/c mice for at least 6 generations.
Mice were used at 6–12 weeks of age.
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Aone Marrow Chimera
6, Aβ−/−, Balb/c, or CIITA−/− recipient mice were lethally irradiated
ith 950 rad of γ-irradiation and rested 1 day prior to receiving
ells. BM cells were prepared from femurs and tibia of donor mice
f 2–3 months of age. Mature lymphocytes were depleted from the
M cell preparation by incubating cells with a cocktail of antibod-
es containing anti-MHC class II (M5/114), anti-CD19 (1D3), anti-
D4 (RL172), and anti-CD8 (TIB105, TIB210) antibodies, followed
y complement-mediated lysis. These cells were subsequently re-
erred to as T-depleted BM cells. Recipient mice were injected with
.5–5 × 106 T-depleted BM cells in 500 l 1× PBS via tail vein.
econstituted mice were analyzed 2–3 months later.
reparation of Thymic Stromal Cells
he thymi were finely minced in cold PBS, and thymocytes were
emoved several times by rocking and allowing the fragments con-
aining TEC to settle for 1 min. The remaining fragments were sub-
ected to enzymatic digestion with 0.25% trypsin (Sigma, St. Louis,
O) and 1 mg/ml DNase I (Sigma) for 30 min at 37°C. After adding
MDM containing 10% fetal bovine serum (Biofluids, Inc., Rockville,
D), the cell suspension was incubated with anti-Fc mAb 2.4G2
or 10 min on ice and then incubated with anti-mouse CD45 micro-
eads (Miltenyi Biotec, Sunnyvale, CA) for 20 min at 4°C. Then, the
ells filtered through nylon mesh were loaded onto a column for
he magnetic bead cell sorting (MACS; Miltenyi Biotec). The effluent
f CD45− cell fraction was collected and centrifuged, and the cells
ere resuspended in FACS buffer (1% BSA plus 0.02% NaN3 in PBS).
low Cytometry
ingle cell-suspensions were prepared from thymi, spleens, and
ymph nodes (pooled from auxiliary, brachial, inguinal, and mesen-
eric). Monoclonal antibodies, biotinylated or conjugated with FITC,
E, PerCP-Cy5.5, or APC against the following antigens, were
sed: B220 (RA3-6B2), CD11c (HL3), CD11b (M1/70), CD4 (RM4-5),
D8 (53-6.7), CD44 (IM7), CD25 (7D4), CD69 (H1.2F3), TCRβ chain
H57-597), NK1.1 (PK136), I-Ab (AF6-120.1), Vβ3 (KJ25), and KJ1-
6 (CALTAG Laboratories, Burlingame, CA). Sreptavidin conjugated
ith FITC, PE, or APC was used to visualize biotinylated antibod-
es. All antibodies were purchased from BD Pharmingen, unless
therwise indicated. For TEC staining, the following monoclonal
ntibodies were used: CD45 (30-F11) from CALTAG Laboratories
nd I-Ab (AF6-120) from BD Pharmingen. The clone secreting anti-
minopeptidase A (CDR1, IgG2a) was purchased from American
ype Culture Collection (Rockville, MD) and prepared by Dr. Larry
antz (NIAID, NIH). Biotinylated UEA-1 was purchased from Vector
aboratories (Burlingame, CA). Flow cytometry was done on a FAC-
Calibur and analyzed with CELLQuest software or FlowJo 6.0
http://www.Flowjo.com).
Cell Proliferation Assays
D4 cell or total splenocytes were labeled with 5 M CFSE (Molec-
lar Probes, Eugene, OR) as described (Chen et al., 2003). In brief,
ells were stained in 1× PBS at 107 cells/ml with periodic agitation
or 10 min at room temperature. After incubation with an equal vol-
me of FBS for 1 min and two washes with growth medium con-
aining 10% FBS, CFSE-labeled cells were plated at 1 × 106 cells/
l in 96-well U-bottom plates with irradiated (3000 rad) T-depleted
plenocytes in a total volume of 300 l per well. For mixed
ymphocyte reactions, total splenocytes or enriched CD4 T cells
rom wt, CIITATg, and CIITATg/CIITA−/−, wt/B6, CIITATg/B6, and
IITATg/Aβ−/− mice were labeled with CFSE and then cocultured
ith either APC from C57BL/6 or Balb/c mice at a T-to-APC ratio
f 10. At day 4, cultured cells were stained with the anti-CD4 anti-
ody, and cell proliferation of live CD4 T cells was determined by
FSE dilution. To examine MHC class II-restricted antigen-specific
esponse, CFSE-labeled splenocytes from AND/CIITA/B6 or
ND/CIITA/Aβ−/− chimeric mice were cocultured with irradiated
-depleted splenocytes from B10.BR mice in the presence of 0, 3,
r 30 g/ml pigeon cytochrome C protein. Similarly, CFSE-labeled
plenocytes from DO/CIITA/Balb/c or DO/CIITA/CIITA−/− chi-
eric mice were cocultured with irradiated Balb/c (I-Ad) T-depleted
plenocytes in the presence of 0, 10, or 100 g/ml OVA protein.
fter 4 days, cultured cells were stained with anti-CD4 and anti-
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385Vβ3 or KJ1-26 antibodies to identify AND or DO11.10 CD4 T cells,
respectively. CFSE dilution by PCC-specific T cells as gated on
Vβ3hiCD4+ or KJ1-26+ CD4 T cells was assessed by flow cytometry.
Functional Assay of CD4+CD25+ Regulatory T Cells
Single-cell suspensions prepared from pooled LN and spleen cells
of B6, CIITATg, and CIITATg/CIITA−/− mice were positively selected
for CD4 T cells using CD4 microbeads (Miltenyi Biotec). The en-
riched cells were then stained with biotin-conjugated anti-CD25
(clone 7D4), PE-labeled anti-CD4 (clone H129.19) (BD Pharmingen),
followed by staining with avidin-conjuated CyChrome and sorted
by FACS. The purity of the CD4+CD25+ populations was >90%.
Sorted CD4+CD25− responder T cells from B6 mice were labeled
with 5 M CFSE as described above. 5 × 104 CFSE-labeled re-
sponder cells were cocultured with anti-CD3 mAb (clone 145-2C11,
at 2 g/ml) and irradiated (3000 rads) T-depleted spleen cells (2 ×
105) from B6 mice in 96-well round-bottom plates in the absence
or presence of 5 × 104 CD4+CD25+ regulatory T cells from B6,
CIITATg, or CIITATg/CIITA−/− mice. Three days later, CD4+CD25− T
cell proliferation was measured by CFSE dye dilution.
Supplemental Data
Supplemental Data include five figures and one table and can be
found with this article online at http://www.immunity.com/cgi/
content/full/23/4/375/DC1/.
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